Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Pastor

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Biomaterials|March 22, 2016
Targeting inhibition of Foxp3 by a CD28 2'-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapyTeresa Lozano, Mario Martínez Soldevilla, Noelia Casares, et al.
Expert Review of Vaccines|November 17, 2011
BiovaxID®: a customized idiotype vaccine for the treatment of B-cell lymphomaHelena Villanueva, Ascension Lopez-Diaz de Cerio, Susana Inoges, et al.
Iscience|February 2, 2026
Pharmacological perturbation of splicing elicits SMG1 reduction: Implications for cancer therapyMartin Barainka, Angelina Zheleva, Angela Pérez-Cervera, et al.
Biomaterials|August 2, 2015
2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasiaMario Martinez Soldevilla, Helena Villanueva, Maurizio Bendandi, et al.
Gut|February 23, 2025
RNA-based therapies in liver metabolic diseasesAntonio Fontanellas, Pedro Berraondo, Francesco Urigo, et al.
Molecular Therapy. Nucleic Acids|August 22, 2022
A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progressionDaniel Meraviglia-Crivelli, Helena Villanueva, Ashwathi Puravankara Menon, et al.
Molecular Therapy. Nucleic Acids|June 26, 2020
Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?Mayte Sola, Ashwathi Puravankara Menon, Beatriz Moreno, et al.
The Journal of Clinical Investigation|December 7, 2007
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in miceJames O McNamara, Despina Kolonias, Fernando Pastor, et al.
Current Topics in Medicinal Chemistry|March 31, 2011
Stem cell transplant and idiotypic vaccination for B-cell malignanciesSusana Inoges, Ascension Lopez-Diaz de Cerio, Antonia Sampol, et al.
Seminars in Oncology|August 31, 2015
Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOSMiguel F Sanmamed, Fernando Pastor, Alfonso Rodriguez, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Biomaterials|March 22, 2016
Targeting inhibition of Foxp3 by a CD28 2'-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapyTeresa Lozano, Mario Martínez Soldevilla, Noelia Casares, et al.
Expert Review of Vaccines|November 17, 2011
BiovaxID®: a customized idiotype vaccine for the treatment of B-cell lymphomaHelena Villanueva, Ascension Lopez-Diaz de Cerio, Susana Inoges, et al.
Iscience|February 2, 2026
Pharmacological perturbation of splicing elicits SMG1 reduction: Implications for cancer therapyMartin Barainka, Angelina Zheleva, Angela Pérez-Cervera, et al.
Biomaterials|August 2, 2015
2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasiaMario Martinez Soldevilla, Helena Villanueva, Maurizio Bendandi, et al.
Gut|February 23, 2025
RNA-based therapies in liver metabolic diseasesAntonio Fontanellas, Pedro Berraondo, Francesco Urigo, et al.
Molecular Therapy. Nucleic Acids|August 22, 2022
A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progressionDaniel Meraviglia-Crivelli, Helena Villanueva, Ashwathi Puravankara Menon, et al.
Molecular Therapy. Nucleic Acids|June 26, 2020
Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?Mayte Sola, Ashwathi Puravankara Menon, Beatriz Moreno, et al.
The Journal of Clinical Investigation|December 7, 2007
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in miceJames O McNamara, Despina Kolonias, Fernando Pastor, et al.
Current Topics in Medicinal Chemistry|March 31, 2011
Stem cell transplant and idiotypic vaccination for B-cell malignanciesSusana Inoges, Ascension Lopez-Diaz de Cerio, Antonia Sampol, et al.
Seminars in Oncology|August 31, 2015
Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOSMiguel F Sanmamed, Fernando Pastor, Alfonso Rodriguez, et al.
Pageof 6